Clinical Trials Directory

Trials / Completed

CompletedNCT05772767

Modulation of Ciliogenesis in Glioma Stem Cells

Control of Growth and Invasiveness of Glioblastoma by Modulation of Ciliogenesis in Glioma Stem Cells. A Novel Target Against Glioblastoma for Precision Medicine. RF-2019-12368786

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims at investigating the cilium-related transcriptome in patients-derived glioblastoma stem cells and the potential impact of modulation of cilium players in vitro, in vivo and ex vivo in glioblastoma brain organoids. Moreover, drugs inhibiting cilia disassembly will be tested. Finally, the potential prognostic role of a cilium-related gene expression signature in glioblastoma will be assessed.

Conditions

Interventions

TypeNameDescription
OTHERBiological sample collectionCollection of tumor tissue and blood for stem cell culture and organoids generation.
OTHERDissecting ciliogenesis playersAssessment of cilium-related transcriptome in glioblastoma stem cells. Modulation of cilium-related genes and administration of cilium-targeted drugs to glioblastoma stem cells in vitro and ex vivo in glioblastoma brain organoids.
DIAGNOSTIC_TESTValidating ciliogenesis playersCilium-related signature will be studied in tumor tissue to evaluate its prognostic role.

Timeline

Start date
2021-02-15
Primary completion
2023-12-31
Completion
2024-07-13
First posted
2023-03-16
Last updated
2025-03-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05772767. Inclusion in this directory is not an endorsement.